Comparison between OM-GA Cu and Copper-T IUCDs.

Area of Science:

• Reproductive Health
• Medical Device Technology
• Clinical Gynecology

Background:

• Intrauterine contraceptive devices (IUCDs) are widely used for birth control.
• Comparing different IUCD models is crucial for optimizing patient outcomes and device selection.
• OM-GA Cu and Copper-T are common IUCDs with distinct designs.

Purpose of the Study:

• To compare the efficacy and side effect profiles of OM-GA Cu and Copper-T IUCDs.
• To evaluate pregnancy, expulsion, and adverse event rates over a two-year period.
• To inform clinical decision-making regarding IUCD choice.

Main Methods:

• A randomized prospective clinical trial involving 200 women.
• Two-year follow-up period to assess outcomes.
• Comparison of dysmenorrhea, dyspareunia, menometrorrhagia, vaginal discharge, pelvic inflammatory disease, pregnancy, and expulsion rates.

Main Results:

• OM-GA Cu users experienced less dysmenorrhea and dyspareunia compared to Copper-T users.
• Pregnancy rates were 5.4% for OM-GA Cu and 3.2% for Copper-T over two years.
• Expulsion rates were significantly higher for OM-GA Cu (11.9%) than for Copper-T (5.3%).
• Rates of menometrorrhagia, vaginal discharge, and pelvic inflammatory disease were similar between both IUCDs.

Conclusions:

• The OM-GA Cu IUCD may offer improved comfort by reducing menstrual pain and painful intercourse.
• The higher expulsion rate of the OM-GA Cu necessitates careful patient counseling and monitoring.
• Both IUCDs demonstrate comparable safety profiles regarding infections and bleeding complications.